This finding aligns with the broader role of MED15 in cancer, as it has been implicated in several other cancer-related processes, including modulation of TGFβ/Smad signaling, promotion of breast cancer cell metastasis, and association with poor prognosis in prostate cancer (31). This evidence concerns the gene TGFB1 and breast carcinoma.